25.11.2022
О. А. Полякова; М. В. Клепикова; Н. М. Долдо; Ю. А. Исаакян; О. Д. Остроумова
phase of COVID‑19, while others experience new symptoms after a mild infection, without any evidence
19.11.2022
А. В. Васильева
electronic medical histories has been accumulated concerning COVID 19 reconvalescents health status. WHO has
18.11.2022
С. Я. Волгина; О. Г. Сачкова; М. М. Садыков; Р. Г. Гамирова; Е. А. Курмаева
, most laboratory and radiographic findings in children with COVID-19 are nonspecific. However, some
13.11.2022
Дж. А. Абдуллозода; Д. Р. Сангинов; З. Х. Хусейнзода
studies related to the impact of COVID-19 on the activities of cancer services in different countries
09.11.2022
И. В. Нестерова; М. Г. Атажахова; В. А. Матушкина; Ю. В. Тетерин; В. Н. Городин; Г. А. Чудилова
Pathophysiology of severe COVID-19 is characterized by changes in the number, phenotype
27.10.2022
В. А. Белаш; А. А. Коршунова; Е. Б. Биличенко; Ю. А. Ламден; А. Н. Куликов
of the ongoing pandemic of COVID-19 (CoronaVirus Disease 2019).
The objective was to develop a personalized
19.10.2022
М. В. Маляревская; О. В. Лукина; А. А. Зубарева; Е. В. Бубнова; И. Б. Баранова; А. I. Yaremenko; А. И. Яременко; М. О. Попова
infection (COVID-19) has increased, including mycoses. Mucormycosis ranks third in the frequency
18.10.2022
Т. В. Глазанова; Е. Р. Шилова
and cellular (primarily T-cell) immunity in the mechanisms of immune defense and resistance to COVID-19
15.10.2022
И. Н. Редькина; Л. А. Суплотова; М. И. Бессонова
cellular mechanisms, and binds the virion to the APF2 receptor. The number of COVID-19 patients is more
15.10.2022
А. В. Бучнева; Н. В. Чичкова; Е. В. Фоминых; Н. В. Крупочкина; В. В. Фомин
. At the moment, the consequences of the transferred COVID-19 need to be studied.
Objective. To study
